Drug Delivery Solutions
NanoOncology
NanoOncology

Investor Information

NanoOncology™ is seeking investment funds to advance its pipeline towards filing of an Investigational New Drug (IND) application for hELP™/EVIRNA™ in the treatment of cancer. Please contact Scott Schneider to obtain copies of an Executive Summary and Private Placement Memorandum.